RiaSTAP 1300 mg/50mL
FIBRINOGEN HUMAN · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · CSL Behring GmbH
RiaSTAP is a injection, powder, lyophilized, for solution containing fibrinogen human at 1300 mg/50mL, taken intravenous. Manufactured by CSL Behring GmbH.
Key Facts
- Brand Name
- RiaSTAP
- Generic Name
- FIBRINOGEN HUMAN
- NDC Code (Product)
63833-891- Manufacturer
- CSL Behring GmbH
- Strength
- 1300 mg/50mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125317
- Marketing Start
- 01/16/2009
Recall History
No Recall HistoryFrequently Asked Questions
What is RiaSTAP used for?
RiaSTAP contains FIBRINOGEN HUMAN. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is RiaSTAP a controlled substance?
RiaSTAP is not classified as a controlled substance by the DEA.
What is the generic name for RiaSTAP?
The generic name for RiaSTAP is FIBRINOGEN HUMAN. There are 12 other brand versions of FIBRINOGEN HUMAN.
What is the NDC code for RiaSTAP 1300 mg/50mL?
The NDC (National Drug Code) for RiaSTAP 1300 mg/50mL is 63833-891, listed by CSL Behring GmbH.
Other Fibrinogen Brands
See all →- TISSEEL Fibrin Sealant0338-4302
- ARTISS Fibrin Sealant86.5 mg/mL0338-9637
- TISSEEL Fibrin Sealant0338-4210
- TISSEEL Fibrin Sealant0338-4211
- EVARREST8.6 mg/cm263713-050
- TISSEEL Fibrin Sealant86.5 mg/mL0338-9560
- ARTISS Fibrin Sealant86.5 mg/mL0338-9639
- Riastap2600 mg/100mL63833-892
- TISSEEL Fibrin Sealant86.5 mg/mL0338-9568
- ARTISS Fibrin Sealant86.5 mg/mL0338-9641
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)